共 32 条
[1]
Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy..RN Boyd;HK Graham;.Eur J Neurol.1999,
[2]
Management of spasticity revisited..Graham LA;.Age Ageing.2013,
[3]
A biomechanical investigation into the validity of the modified Ashworth Scale as a measure of elbow spasticity..Pandyan Anand D;Price Christopher I M;Barnes Michael P;Johnson Garth R;.Clinical rehabilitation.2003,
[4]
....,
[5]
[6]
Toward an epidemiology of poststroke spasticity.[J].J?rg Wissel;Aubrey Manack;Michael Brainin.Neurology.2013, 3_Su
[7]
Assessing and treating functional impairment in poststroke spasticity.[J].Katharina S. Sunnerhagen;John Olver;Gerard E. Francisco.Neurology.2013, 3_Su
[9]
Five‐year experience with incobotulinumtoxinA (Xeomin<sup>?</sup>): the first botulinum toxin drug free of complexing proteins.[J].D.Dressler.European Journal of Neurology.2012, 3
[10]
Successful Treatment of Long-Term, Poststroke, Upper-Limb Spasticity With OnabotulinumtoxinA
[J].
PHYSICAL THERAPY,
2011, 91 (11)
:1636-1641

